site stats

Inzy earnings

WebInozyme Pharma (INZY) will release its next earnings report on May 10, 2024. In the last quarter Inozyme Pharma reported -$0.452 EPS in relation to -$0.31 expected by the market. Web12 apr. 2024 · Inozyme Pharma is trading at a lower price-to-earnings ratio than RenovoRx, indicating that it is currently the more affordable of the two stocks. Summary Inozyme Pharma beats RenovoRx on 7 of the ...

Overview - Inozyme Pharma, Inc.

Web13 apr. 2024 · INZY Inozyme Pharma, Inc. Earnings Date & History 788 followers ( +14.89% 3:59 PM 04/06/23 NASDAQ $USD Pre-Market: $5.68 +0.01 (+0.18%) 6:37 … Web31 mrt. 2024 · INZY Inozyme Pharma, Inc. Earnings Surprise 745 followers $5.73 1.04 ( +22.17%) 4:00 PM 03/31/23 NASDAQ $USD Post-Market: $5.67 -0.06 (-1.05%) 7:56 PM Summary Ratings Financials Earnings... crypto map vs ipsec profile https://simul-fortes.com

Inozyme Pharma, Inc. (INZY) 10K Annual Reports & 10Q SEC Filings

Web16 mrt. 2024 · This suggests that analysts have very recently bumped up their estimates for INZY, giving the stock a Zacks Earnings ESP of +12.11% heading into earnings season. Inozyme Pharma, Inc. Price... Web11 apr. 2024 · BOSTON, April 11, 2024 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical- stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferation, today announced Douglas A. Treco, Ph.D., the company’s chief executive officer and chairman … WebINZY Complete Inozyme Pharma Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. crypto margin calls

Inozyme Pharma, Inc. Expected to Post Q1 2024 Earnings of …

Category:Comparing RenovoRx (NASDAQ:RNXT) & Inozyme Pharma (NASDAQ:INZY)

Tags:Inzy earnings

Inzy earnings

Why Earnings Season Could Be Great for Inozyme (INZY)

Web22 mrt. 2024 · The following information was filed by Inozyme Pharma, Inc. (INZY) on Wednesday, March 22, 2024 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the … WebFor their last quarter, Inozyme Pharma (INZY) reported earnings of -$0.38 per share, beating the Zacks Consensus Estimate of $-0.43 per share. This reflects a positive …

Inzy earnings

Did you know?

WebInozyme (INZY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. GlobeNewswire. Inozyme Pharma to Participate in the Cowen 43rd Annual Health Care Conference. BOSTON, March 01, 2024 (GLOBE NEWSWIRE) ... WebFind the latest Earnings Report Date for Inozyme Pharma, Inc. Common Stock (INZY) at Nasdaq.com. Inozyme Pharma, Inc. Common Stock (INZY) Earnings Report Date …

WebEarnings Summary For their last quarter, Inozyme Pharma (INZY) reported earnings of -$0.38 per share, beating the Zacks Consensus Estimate of $-0.43 per share. This reflects a positive... Web25 mrt. 2024 · INZY opened at $3.60 on Friday. Inozyme Pharma has a one year low of $0.99 and a one year high of $6.25. The company has a market cap of $145.42 million, a P/E ratio of -1.90 and a beta of 0.79.

Web11 apr. 2024 · According to the issued ratings of 4 analysts in the last year, the consensus rating for Inozyme Pharma stock is Buy based on the current 4 buy ratings for INZY. The … WebQuarterly Numbers. Actuals. Estimates. INZY will report Q1 2024 earnings on 09/07/2024. Q1 2024. Q2 2024. Q3 2024.

Web14 apr. 2024 · RenovoRx (NASDAQ:RNXT – Get Rating) and Inozyme Pharma (NASDAQ:INZY – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, valuation, analyst recommendations, institutional ownership and …

Web13 apr. 2024 · We use cookies to personalize content and ads, provide social media features, and, analyze our traffic. We also share information about your use of our site … crypto margin trading exchangeWebInozyme Pharma (INZY) Earnings, Revenues Date & History. Earnings. Revenues. The upcoming earnings date is based on a company’s previous reporting, and may be … crypto margin lending ratesWebInozyme (INZY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. Benzinga. Why Inozyme Pharma (INZY) ... crypto margin trading canadaWebOn Invalid Date, Inozyme Pharma (NASDAQ: INZY) reported Q4 2024 earnings per share (EPS) of -$0.42, up 46.84% year over year. Total Inozyme Pharma earnings for the quarter were -$18.54 million. In the same quarter last year, Inozyme Pharma's earnings per share (EPS) was -$0.79. crypto margin trading platformsWeb2 dagen geleden · Inozyme Pharma (INZY) (Delayed Data from NSDQ) $5.89 USD +0.45 (8.27%) Updated Apr 11, 2024 04:00 PM ET After-Market: $5.89 0.00 (0.00%) 7:58 PM … crypto margin trading demoWebINZY - Inozyme Pharma, Inc. Stock Price and Quote TIP: Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. × publish chart save to portfolio create alert compare perf. Candle - advanced Intraday Daily Weekly Draw Fullscreen Settings INZY - Stock Price Chart INZY [NASD] Inozyme Pharma, Inc. crypto margin trading exchangesWebInozyme Pharma Inc. analyst ratings, historical stock prices, earnings estimates & actuals. INZY updated stock price target summary. Dow Jones, a News Corp company About WSJ crypto margin trading bot